|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
WuXi AppTec
| WuXi AppTec 9765 Clairemont Mesa Blvd, Suite C San Diego, CA 92124 | |
| | Phone: | (858) 622-0099 | Fax: | (858) 622-1999 | Year Established: | 2008 | Main Contact: | Felix Hsu, Senior VP, US a&Global Business Development | | Other Contacts: | Steve Yang, Ph.D., Executive VP & COO Hua Mu. MD, Head Product Development Service & Partnership Business Suhan Tang, Ph.D., Chief Manufacturing Officer Shuhui Chen, Ph.D., CSO Edward Hu, CFO & Chief Investment Officer Ge Li, Ph.D., Chairman & CEO
| | Company Description | WuXi PharmaTech (pronounced woo-shee pharma-tek) is a leading global contract research outsourcing provider, serving the worldwide pharmaceutical, biotech, and medical device industries. The company is headquartered in Shanghai and has operations in both China and the United States. We provide a broad and integrated portfolio of laboratory and manufacturing services throughout the R&D process. Our services are designed to help our global partners shorten the time and lower the cost of R&D. The parent company is known as WuXi PharmaTech, and its operating divisions are known as WuXi AppTec.
WuXi PharmaTech is the product of the merger in early 2008 of WuXi PharmaTech Inc., a chemistry-based company founded in China in 2000, and AppTec Laboratory Services Inc., a U.S. company founded in 2001 with expertise in medical-device and biologics testing. WuXi PharmaTech Inc. expanded its services rapidly throughout the decade, offering discovery chemistry services in 2001; process development in 2003; research manufacturing in 2004; bioanalytical chemistry in 2005; service biology in 2006; toxicology and formulation in 2007; commercial manufacturing in 2009; genomics, clinical trial management and research reagents in 2011; and biologics discovery, development and manufacturing in 2012. | |
|
|
|
|
|